EEG and urinary non-catecholic amine changes during L-dopa therapy of Parkinson's disease.
D001921:Brain / Q000503:physiopathology*; D002247:Carbon Isotopes; D003404:Creatinine / Q000652:urine; D004295:Dihydroxyphenylalanine / Q000378:metabolism / Q000627:therapeutic use*; D004569:Electroencephalography; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology / Q000652:urine; D010648:Phenylacetates / Q000652:urine; D014363:Tryptamines / Q000652:urine; D014439:Tyramine / Q000096:biosynthesis / Q000652:urine*
D002247:Carbon Isotopes; D010648:Phenylacetates; D014363:Tryptamines; D004295:Dihydroxyphenylalanine; D003404:Creatinine; D014439:Tyramine